my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
Founded in 1998 on the initiative of researchers from the Academic Medical Center (AMC) in Amsterdam, AMT has become a leader in the field of human gene therapy. A pioneer in the development of gene therapy AMT has used its scientific know-how and expertise to build up a strong research and clinical more
Amsterdam Molecular Therapeutics (AMT) Holding N.V. in liquidation (in liquidatie), announced that following the approval of the corporate restructuring and financing transaction by the Extraordinary General Meeting ("EGM") of shareholders that was held on 30 March 2012, completion of the disposal o more
Amsterdam Molecular Therapeutics announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to its gene therapy program for the treatment of hemophilia B. Orphan designation in the U.S. could provide up to seven years market exclusivity on regulatory approval. Orp more
Amsterdam Molecular Therapeutics announced that the Company has raised € 2.5 million in new equity by means of a private placement to three of its existing shareholders: Forbion Capital Partners, Gilde Healthcare Partners and Advent Venture Partners. Under the terms of the transaction, AMT has agree more
OctoPlus N.V. (OctoPlus) operates as a drug delivery company, engaged in the development of improved pharmaceutical products. The company's business activities include formulation development services, drug delivery technologies and controlled release product development. It products portfolio inclu more
Search Home Contact Us Products Transfection Reagents In Vivo Reagents / Therapeutics Biomanufacturing Technical Resources Download Ordering Information Technologies Polyplus’ Expertise: Transfection ZNA™ Modified Oligonucleotide Delivery Solutions for Therapeutic Nucleic Acids STICKY SIRNA™ Partner more
Impressum | SiteMap U3 Pharma An innovative biotech company U3 Pharma GmbH, based in Martinsried near Munich, Germany, is a leader in targeted cancer drug development. Established in July 2001, the company has produced a pipeline of novel targeted therapeutics based on the ground-breaking discover more
A A Home About Us Investors Management Board of Directors Scientific Advisory Board Technologies Antibodies Overview Intellectual Property Glossary Partnering Press Room Career Contact Maps & Directions Basel Site Maps & Directions Jena Site Press Room Recent news releases March 16, 2010: 4-Antibody more
Watchlist
This is where you can add this topic to your personal favourites
Über CHEMIE.DE
CHEMIE.DE Information Service GmbH runs specialist scientific internet portals. The secret to our success? We are familiar with what we publish.
Advertising at CHEMIE.DE
Our advertising formats support you in getting your message across to a clearly defined target audience.
© 1997-2013 CHEMIE.DE Information Service GmbH, All rights reserved
Netmeeting
